NURO — NeuroMetrix Cashflow Statement
0.000.00%
Last trade - 00:00- $8.94m
- -$4.16m
- $3.03m
- 20
- 42
- 82
- 46
Annual cashflow statement for NeuroMetrix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.09 | -2.28 | -4.42 | -6.53 | -7.81 |
| Depreciation | |||||
| Non-Cash Items | 0.993 | 1.36 | 0.79 | 0.263 | 0.013 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.06 | -1.23 | -1.71 | 0.126 | 0.57 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -2.07 | -2.07 | -5.29 | -6.08 | -7.13 |
| Capital Expenditures | 0 | -0.132 | -0.023 | -0.184 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | -16.9 | 1.34 | 5.35 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 0 | -0.132 | -16.9 | 1.16 | 5.35 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.17 | 19.6 | 3.86 | 2.33 | 1.48 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.1 | 17.3 | -18.3 | -2.6 | -0.304 |